Newron Pharmaceuticals S.p.A.

Rachunek Zysków i Strat





index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
Rok finansowy 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 1 4 4 3 1 0 9 4 2 2 7 13 4 7 5 6 6 9 51
Przychód Δ r/r 0.0% inf% 237.9% -2.3% -35.4% -68.3% -65.3% 3087.1% -60.3% -56.0% 52.9% 182.6% 99.6% -70.0% 74.9% -25.3% 9.6% 5.8% 48.6% 467.4%
Marża brutto 0.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 99.7% 92.4% 69.4% 47.0% 60.8% 100.0% 65.9% 79.8% 94.4% 100.0% 100.0% 100.0% 100.0%
EBIT (mln) -15 -17 -14 -18 -25 -22 -6 -3 -8 -9 -18 -15 -4 -15 -21 -18 -12 -13 -12 26
EBIT Δ r/r 0.0% 11.1% -18.3% 33.9% 34.0% -11.9% -70.0% -58.4% 188.3% 16.9% 94.4% -13.3% -73.3% 265.7% 39.5% -13.6% -31.6% 7.6% -12.6% -325.1%
EBIT (%) 0.0% -1406.5% -340.0% -465.8% -966.0% -2684.9% -2315.0% -30.2% -219.7% -583.8% -742.6% -227.8% -30.5% -372.1% -296.9% -343.6% -214.5% -218.3% -128.4% 50.9%
Koszty finansowe (mln) -0 -0 -3 -2 -0 0 0 0 -0 0 0 0 0 0 1 2 3 4 4 4
EBITDA (mln) -15 -17 -14 -18 -24 -21 -6 -2 -8 -9 -18 -15 -4 -15 -21 -18 -12 -13 -12 26
EBITDA(%) 0.0% -1406.5% -336.4% -458.9% -945.4% -2666.4% -2261.4% -27.1% -218.6% -581.7% -739.7% -227.4% -30.1% -367.4% -296.2% -342.2% -213.6% -217.7% -130.6% 50.5%
Podatek (mln) -0 -0 0 0 -1 -1 0 -0 -1 1 2 0 0 0 0 1 0 0 0 6
Zysk Netto (mln) -15 -16 -11 -16 -23 -21 -6 -2 -7 -10 -23 -15 -5 -15 -20 -21 -15 -17 -16 16
Zysk netto Δ r/r 0.0% 9.9% -32.4% 47.6% 43.5% -12.5% -68.6% -63.1% 198.9% 42.2% 126.0% -33.2% -65.3% 184.6% 34.4% 3.9% -29.0% 17.4% -7.3% -197.7%
Zysk netto (%) 0.0% -1377.1% -275.6% -416.1% -923.7% -2549.0% -2301.8% -26.6% -200.6% -648.4% -958.7% -226.5% -39.3% -373.5% -287.1% -399.4% -258.6% -287.1% -179.1% 30.8%
EPS -5.29 -4.33 -1.9 -2.74 -3.86 -3.11 -0.89 -0.29 -0.62 -0.8 -1.66 -1.04 -0.32 -0.84 -1.13 -1.18 -0.84 -0.98 -0.91 0.85
EPS (rozwodnione) -5.29 -4.33 -1.9 -2.74 -3.86 -3.11 -0.89 -0.29 -0.62 -0.8 -1.66 -1.04 -0.32 -0.84 -1.13 -1.18 -0.84 -0.98 -0.91 0.85
Ilośc akcji (mln) 3 4 6 6 6 7 7 8 12 13 14 15 16 18 18 18 18 18 18 19
Ważona ilośc akcji (mln) 3 4 6 6 6 7 7 8 12 13 14 15 16 18 18 18 18 18 18 19
Waluta EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR